Making adjuvant therapy decisions with uncertain data-Reference-Cited by-同舟云学术

Making adjuvant therapy decisions with uncertain data

Published:2019-03 Issue:3 Volume:30 Page:361-364
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Gyawali B.^ORCID,Prasad V.

Funder

Laura and John Arnold Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/30/3/361/28255144/mdz039.pdf

Reference9 articles.

1. The strength of association between surrogate end points and survival in oncology: a systematic review of trial-level meta-analyses;Prasad;JAMA Intern Med,2015

2. Adjuvant EGFR TKI therapy for resectable non-small cell lung cancer: new era for personalized medicine;Shen;J Thorac Dis,2018

3. FDA approves neratinib for extended adjuvant treatment of early stage HER2-positive breast cancer 2017; https://www.fda.gov/drugs/informationondrugs/approveddrugs/ucm567259.htm (29 October 2018, date last accessed).

4. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial;Chan;Lancet Oncol,2016

5. Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer;von Minckwitz;N Engl J Med,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of tumor-infiltrating lymphocytes with clinical outcomes in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a systematic review and meta-analysis;Clinical and Translational Oncology;2024-08-18

2. Decision-Making at Swissmedic, the Swiss Regulatory Agency, with a Focus on (Neo)adjuvant Cancer Treatments;Oncology;2024-03-05

3. Adjuvant immunotherapy for locally advanced renal cell carcinoma;Expert Opinion on Biological Therapy;2023-12-02

4. Adjuvant therapy for stage IIB + IIC melanoma;Journal of Surgical Oncology;2023-11-30

5. Publicly Funded Cancer Care: Are Adjuvant Therapies Prioritized Over Treatment of Metastatic Cancer? The Israeli Experience;JCO Oncology Practice;2023-11-15